Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03988309 · ClinicalTrials.gov registry record · NA
STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA
A NA study of Urothelial Carcinoma and Hematuria, sponsored by Pacific Edge Limited.
- Completed
- Registry status
- NA
- Development phase
- 554
- Enrollment target
- 12
- Study locations
NCT03988309 is a NA study of Urothelial Carcinoma and Hematuria that has completed, run by Pacific Edge Limited. The registered enrollment target is 554 participants, above the 233-participant average among 85 other Urothelial Carcinoma trials with a reported enrollment target (138% higher). The trial reports 12 study locations across 10 states.
The verdict
NCT03988309, a NA study of Urothelial Carcinoma and Hematuria, has completed, sponsored by Pacific Edge Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 554 participants
- Enrollment target
- 12
- Study locations
Study Summary
To evaluate the clinical utility associated with the integration of Cxbladder into the evaluation of subjects presenting with hematuria for evaluation of urothelial carcinoma (UC) without compromising detection of UC.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cxbladder
Study Locations (12)
Minnesota
- Allina Health Cancer Institute - Minneapolis
- University of Minnesota, Department of Urology - Minneapolis
Texas
- UT Southwestern Medical Center - Dallas
- UTHSA - Mays Cancer Center - San Antonio
California
- Institute of Urology, USC Norris Comprehensive Cancer Center - Los Angeles
Florida
- Avant Concierge Urology - Winter Garden
Illinois
- Accellacare - Chicago
Pennsylvania
- Division of urology, Penn State Milton S Hershey Medical Center - Hershey
South Carolina
- Carolina Urologic Research Center - Myrtle Beach
Tennessee
- Department of Urology,Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 554 participants |
| Start Date | 2019-09-11 |
| Est. Completion | 2024-07-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03988309
The ClinicalTrials.gov registry entry for NCT03988309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 554 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 233-participant average among 85 other Urothelial Carcinoma trials with a reported enrollment target (138% higher). The listed sponsor is Pacific Edge Limited, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Urothelial Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Cxbladder is the first listed.
NCT03988309 reports 12 study locations spanning 10 distinct geographic areas - top geographies include Minnesota, Texas, California.
Frequently Asked Questions
What is clinical trial NCT03988309 about?
NCT03988309 is a clinical study titled "STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA". To evaluate the clinical utility associated with the integration of Cxbladder into the evaluation of subjects presenting with hematuria for evaluation of urothelial carcinoma (UC) without compromising detection of UC.
What is the current status of trial NCT03988309?
This trial is currently completed. It is a NA study. The enrollment target is 554 participants. The study started on 2019-09-11. Estimated completion is 2024-07-24.
What conditions does trial NCT03988309 study?
This clinical trial studies the following conditions: Urothelial Carcinoma, Hematuria.
What interventions are being tested in trial NCT03988309?
The interventions under investigation include: Cxbladder (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03988309?
This trial is sponsored by Pacific Edge Limited, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03988309 being conducted?
This trial has 12 study locations across California, Florida, Illinois, Minnesota, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urothelial Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
RECRUITING · NA
-
Bladder Cancer Screening Trial
RECRUITING · NA
-
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
RECRUITING · NA
-
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
RECRUITING · NA
-
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
RECRUITING · NA
-
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.